Iceland· IS-EU/1/14/987/001
Holoclar
A limbale stammzellen, autolog product containing ex vivo expanded autologous human corneal epithelial cells containing stem cells, registered in Iceland by Holostem S.r.l.. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Limbale stammzellen, autolog is registered in 8 of 19 countries.
Countries holding a registration under ATC S01XA19 (limbale stammzellen, autolog), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 5 of them publish a price we can compare per daily dose
Limbale stammzellen, autolog · ATC S01XA19
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Ex vivo expanded autologous human corneal epithelial cells containing stem cells
- Manufacturer
- Holostem S.r.l.
- Country
- Iceland (IS)
- ATC code
- S01XA19
- ATC class
- Limbale Stammzellen, autolog
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01XA19
Limbale stammzellen, autolog, as other registers publish it.
- PolandHoloclarHolostem s.r.l.
- FinlandHoloclarHolostem s.r.l
- DenmarkHoloclarHolostem Terapie Avanzate S.r.l.
- CzechiaHOLOCLARHolostem s.r.l., Modena
- IrelandHoloclar 79,000 - 316,000 cells/cm2 living tissue equivalentHolostem S.r.l.
- BelgiumHoloclar 79000 cells/cm² - 316000 cells/cm²Holostem
- NetherlandsHoloclar, levend weefsel equivalentHolostem s.r.l.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07b779bd-c794-4542-ac2d-65afab7787e7 GET /v1/drugs/07b779bd-c794-4542-ac2d-65afab7787e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Ígildi lifandi vefs",
"source": "lyfjastofnun",
"atc_raw": "S01XA19",
"marketed": false,
"strength": "79.000-316.000 frumur/ cm2",
"ma_number": "EU/1/14/987/001",
"substance": "Ex vivo expanded autologous human corneal epithelial cells containing stem cells",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "42052"
}See everything about limbale stammzellen, autolog.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.